University Hospital of North Durham; Oncology
About University Hospital of North Durham; Oncology
University Hospital of North Durham is an acute care hospital built to replace the older Dryburn Hospital on the same site. It is managed by the County Durham and Darlington NHS Foundation Trust.
There are 523 beds in University Hospital of North Durham; Oncology.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at University Hospital of North Durham; Oncology
During the past decade, University Hospital of North Durham; Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block
2012-11-01
2013-11-01
Withdrawn
0
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
2015-10-15
Active, not recruiting
1,378
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
2016-12-08
2023-02-15
Terminated
3,021
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University Hospital of North Durham; Oncology
According to Clinical.Site data, the most researched conditions in "University Hospital of North Durham; Oncology" are
"Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "University Hospital of North Durham; Oncology" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital of North Durham; Oncology
Most popular intervention types in "University Hospital of North Durham; Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (2 trials), "Bevacizumab" (1 trials), "Capecitabine/Oxaliplatin" (1 trials), "Fluorouracil +/- Folinic Acid" (1 trials) and "Fluorouracil/Folinic Acid/Irinotecan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital of North Durham; Oncology
The vast majority of trials in "University Hospital of North Durham; Oncology" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at University Hospital of North Durham; Oncology
Currently, there are NaN active trials in "University Hospital of North Durham; Oncology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in University Hospital of North Durham; Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital of North Durham; Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".